Page data last changed: . Chemistry registry snapshot: . Registry refreshes and identity assessments are separate from scientific content review.
A cardiac hormone released on atrial stretch that lowers blood volume and pressure.
Also known as: ANP · ANF · NPPA
Part of the Foundational & therapeutic peptides cluster
Overview
Atrial natriuretic peptide (ANP) is a 28-residue cardiac hormone secreted by the atria in response to stretch. Encoded by NPPA, it signals through the NPR-A guanylyl-cyclase receptor to promote sodium and water excretion, vasodilation and reduced blood volume. This page is educational and not medical advice.
Source & context
Biological / chemical source: Secreted by cardiac atria; encoded by the NPPA gene
Primary research or clinical context: Cardiovascular and fluid-balance physiology research
Release and signaling
ANP is stored as proANP in atrial granules and cleaved to the active 28-residue form when atrial wall stretch signals volume overload. It binds natriuretic peptide receptor A (NPR-A), raising cGMP to trigger renal sodium excretion and smooth-muscle relaxation.
Physiological role
By opposing the renin-angiotensin-aldosterone system, ANP helps defend against extracellular volume expansion and hypertension. It also limits cardiac hypertrophy and vascular remodeling, and its measurement is used in cardiovascular research alongside BNP.
Structure & chemistry
Molecular identity & reference confidence
Source-supported reference
Reference values are taken from the cited molecular record or curated profile. A database match is not independent laboratory verification; modifications, counter-ions, and formulations can change the measured mass.
- Molecular form
- Atrial natriuretic peptide (source record; form not independently established)
- Species
- Not established by this molecular identity audit
- Termini (N / C)
- Not specified / Not specified
Average reference mass
Reference policy updated: 2026-10-05
- IUPHAR/BPS source snapshot · 2026-09-06
- PubChem molecular record · 2026-09-06
- Molecular formula
- C127H203N45O39S3
- Average reference mass
- ≈ 3,080.5
- PubChem CID: 16129708
- IUPHAR ligand: 4869
- CAS RN: 89213-87-6
- UNII: GZ8FA500J0
Chemistry values: PubChem, IUPHAR/BPS Guide to Pharmacology · fetched 2026-09-06.
Clinical development snapshot
ClinicalTrials.gov lists 46 registered studies with “Atrial natriuretic peptide” as an intervention (snapshot 2026-10-01). A registry footprint is not evidence of efficacy or approval.
| NCT | Title | Phase | Status | Updated |
|---|---|---|---|---|
| NCT06343298 | To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension | Phase 2 | recruiting | 2026-09-23 |
| NCT07606183 | Effects of Different Forms of a Natural Heart Hormone on Blood Pressure and Fluid Balance in Healthy Volunteer | Early phase 1 | completed | 2026-05-26 |
| NCT05216042 | GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study | Not applicable | recruiting | 2026-04-09 |
| NCT07057466 | Prospective Evaluation of AI-ECG for SHD Detection | — | recruiting | 2026-03-09 |
| NCT07421622 | Management of Epistaxis Comparing Nasal Packing Versus Greater Palatine Foramen Block | Not applicable | not yet recruiting | 2026-02-24 |
| NCT06327529 | Zinc and Iron Absorption From Common Beans in Young Adult Women | Not applicable | recruiting | 2026-02-20 |
Atrial natriuretic peptide — reconstitution calculator
Enter how much peptide is in the vial and how much diluent (e.g. bacteriostatic water) is added. The tool returns the resulting solution concentration — and, for any amount you type, the volume it corresponds to. This is educational arithmetic, not a dosing recommendation.
Reference form: Atrial natriuretic peptide (source record; form not independently established)Average reference mass: 3,080.5 Da
Enter an amount to see the volume it corresponds to.
Educational concentration mathematics only. This tool does not recommend a dose, amount, or protocol, and nothing here is medical advice. Many peptides are not authorized by Health Canada for human use — see our reconstitution and bacteriostatic-water guides for context.
FAQ about Atrial natriuretic peptide
What is Atrial natriuretic peptide?+
Atrial natriuretic peptide (ANP) is a 28-residue cardiac hormone secreted by the atria in response to stretch. Encoded by NPPA, it signals through the NPR-A guanylyl-cyclase receptor to promote sodium and water excretion, vasodilation and reduced blood volume. This page is educational and not medical advice.
What Canadian product status is recorded for Atrial natriuretic peptide?+
Canadian product status for Atrial natriuretic peptide has not been verified in this profile. No verified record here does not mean no authorization exists. Status depends on the product, formulation and use; consult Health Canada's product records.
What is the typical length of Atrial natriuretic peptide?+
Atrial natriuretic peptide is commonly described as approximately 28 amino acids (Peptide hormone (natriuretic peptide)).
Related peptides
References & further reading
- 1.Cogan (1990). Atrial natriuretic peptide. Kidney Int
- 2.Naruse et al. (1989). [Atrial natriuretic peptide]. Kokyu To Junkan
- 3.Pruszczyński (1987). [Atrial natriuretic peptide]. Pol Tyg Lek
- 4.Wambach (1988). [Atrial natriuretic peptide]. Med Klin (Munich)
- 5.Espiner et al. (1987). Human atrial natriuretic peptide. Clin Endocrinol (Oxf)
- 6.Fu et al. (2022). Pleiotropic Roles of Atrial Natriuretic Peptide in Anti-Inflammation and Anti-Cancer Activity. Cancers (Basel)
- 7.Choi et al. (2021). Protective Renal Effects of Atrial Natriuretic Peptide: Where Are We Now?. Front Physiol
- 8.Lu et al. (2023). Regulatory role of atrial natriuretic peptide in brown adipose tissue: A narrative review. Obes Rev
- 9.PMC — Atrial natriuretic peptide in cardiovascular biology and disease (NPPA)
- 10.Wikipedia — Atrial natriuretic peptide